Brand / Product: Ricovir‑EM Tablet Strength: 300 mg / 200 mg per tablet – this refers to: Tenofovir disoproxil fumarate: 300 mg Emtricitabine: 200 mg Active Ingredients Tenofovir disoproxil fumarate (TDF) – 300 mg • A nucleotide reverse transcriptase inhibitor (NRTI) that blocks HIV replication. Emtricitabine (FTC) – 200 mg • A nucleoside reverse transcriptase inhibitor (NRTI) that also stops HIV from multiplying. Dosage Form Film-coated oral tablets Typically taken once daily with or without food, as prescribed by a healthcare provider. Therapeutic Class Antiviral / Antiretroviral combination Classified under NRTIs (Nucleoside/Nucleotide Reverse Transcriptase Inhibitors). Indications (Uses) Treatment of HIV‑1 infection (in adults and adolescents) as part of combination antiretroviral therapy. Pre‑Exposure Prophylaxis (PrEP) to reduce the risk of acquiring HIV in HIV‑negative individuals at high risk. Treatment of HIV-1 Infection Ricovir‑EM is a combination antiretroviral medication containing Tenofovir (300 mg) and Emtricitabine (200 mg). It is used as part of combination therapy to control HIV-1 viral replication in adults and adolescents. Helps reduce viral load, maintain immune function, and slow disease progression. Pre-Exposure Prophylaxis (PrEP) For HIV-negative individuals at high risk of infection (e.g., partners of HIV-positive people). Taken once daily to significantly reduce the risk of acquiring HIV. Post-Exposure Prophylaxis (PEP) (less common but sometimes used) May be part of a regimen for short-term treatment after potential HIV exposure (usually combined with other antiretrovirals). Ricovir EM (200 mg Emtricitabine/300 mg Tenofovir Disoproxil Fumarate) is a combination antiretroviral medicine used to treat and prevent HIV-1 and treat chronic Hepatitis B. It belongs to the class of drugs known as Nucleoside Reverse Transcriptase Inhibitors (NRTIs), which work by stopping the virus from replicating. Key Details for Ricovir EM 300 mg (10/300mg variant): Therapeutic Category: Antiretroviral, Antiviral.Drug Class: Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (NRTI).Components: Tenofovir Disoproxil Fumarate ((300text{mg})) + Emtricitabine ((200text{mg})).Uses: HIV-1 treatment/prevention (PrEP), and Chronic Hepatitis B.Key Action: Inhibits HIV reverse transcriptase and hepatitis B DNA polymerase.Pregnancy Category: Category B.